Table 1.
Patients (n) | 152 |
---|---|
Age | 63.7±7.2 years |
PSA | 5.25±4.22 ng/mL |
Tumor volume | 14.4±12.9 mL |
PNI | 32.9% (50/152) |
SVI | 11.8% (18/152) |
ECE | 19.7% (30/152) |
CI | 13.2% (20/152) |
PSM | 11.8% (18/152) |
BCR | 25% (38/152) |
PSA: prostate-specific antigen; PNI: perineural invasion; SVI: seminal vesicle invasion; ECE: extracapsular extension; CI: capsule invasion; PSM: positive surgical margins; BCR: biochemical recurrence